Getting the Best Results With MIRVASO Gel
How to Apply MIRVASO Gel
What to Expect From MIRVASO Gel
For most patients, the MIRVASO Gel effect is powerful.
Skin that has been red for days, months, or even years
may suddenly look "normal" again. But remember:
|MIRVASO Gel is not a cure for rosacea
Your redness will return after the effect of the medication wears off
|Some patients have reported that their redness returned worse than it appeared before
This could be due to exposure to triggers or it may simply be a return to your natural complexion, which may be alarming after seeing yourself without the usual redness. Common triggers include: spicy food; stress and anxiety; hot drinks, such as coffee and tea; alcohol, such as red wine; physical activity, such as exercise; sun exposure; extreme hot or cold environments; and certain skin-care products. Avoid your triggers, even while you are using MIRVASO Gel
|Tell your doctor about side effects
In clinical trials, about 10% of subjects reported worsening of redness while using MIRVASO Gel. In every case this side effect was temporary and went away on its own. However, if you are concerned that you may be experiencing a side effect while using MIRVASO Gel, speak to your physician or dermatologist right away
Important Safety Information
Indication: MIRVASO® (brimonidine) topical gel, 0.33%* is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: MIRVASO Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. MIRVASO Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of MIRVASO Gel by children have been reported. Keep MIRVASO Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
All trademarks are the property of their respective owners.